Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4RA0

An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis

Summary for 4RA0
Entry DOI10.2210/pdb4ra0/pdb
DescriptorGrowth arrest-specific protein 6, Tyrosine-protein kinase receptor UFO, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (8 entities in total)
Functional Keywordsaxl, gas6, cancer, metastasis, signaling protein
Biological sourceHomo sapiens (human)
More
Total number of polymer chains4
Total formula weight132492.68
Authors
Kariolis, M.S.,Kapur, S.,Mathews, I.I.,Cochran, J.R. (deposition date: 2014-09-09, release date: 2014-09-24, Last modification date: 2024-10-30)
Primary citationKariolis, M.S.,Miao, Y.R.,Jones, D.S.,Kapur, S.,Mathews, I.I.,Giaccia, A.J.,Cochran, J.R.
An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis.
Nat.Chem.Biol., 10:977-983, 2014
Cited by
PubMed Abstract: Aberrant signaling through the Axl receptor tyrosine kinase has been associated with a myriad of human diseases, most notably metastatic cancer, identifying Axl and its ligand Gas6 as important therapeutic targets. Using rational and combinatorial approaches, we engineered an Axl 'decoy receptor' that binds Gas6 with high affinity and inhibits its function, offering an alternative approach from drug discovery efforts that directly target Axl. Four mutations within this high-affinity Axl variant caused structural alterations in side chains across the Gas6-Axl binding interface, stabilizing a conformational change on Gas6. When reformatted as an Fc fusion, the engineered decoy receptor bound Gas6 with femtomolar affinity, an 80-fold improvement compared to binding of the wild-type Axl receptor, allowing effective sequestration of Gas6 and specific abrogation of Axl signaling. Moreover, increased Gas6 binding affinity was critical and correlative with the ability of decoy receptors to potently inhibit metastasis and disease progression in vivo.
PubMed: 25242553
DOI: 10.1038/nchembio.1636
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.07 Å)
Structure validation

245663

数据于2025-12-03公开中

PDB statisticsPDBj update infoContact PDBjnumon